$0.16
▼ -6.5% Today
as of Oct 22, 16:53 ET
Last 30 days
Recent Press Releases & News
VivoSim Labs Extends NAMkind Platform with Human Disease Models for Efficacy Testing and Mechanistic Biomarker Profiling
VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods
VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs
VIVS earnings at a glance
VivoSim Labs, Inc. (VIVS) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. The share price of $0.16 sits near its 52-week low.
Overview
52-week range
$0.15
$3.40
0% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.25 | — | — | — | — | financials |
| Wed Dec 31, 2025 | Dec 2025 | $-1.03 | — | — | — | — | financials |
| Thu Nov 6, 2025 | Sep/2025 | $-0.98 | — | — | — | — | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-1.14 | — | — | — | — | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $-2.28 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-1.68 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-2.74 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-0.40 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.46 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.46 | — | — | — | — | financials |
| Sat Dec 31, 2022 | Dec 2022 | $-0.37 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Nov 5, 2026 | Sep/2026 | OTHER | — | -$0.98 |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18,000 | — | $26,000 | $28,000 | $37,000 | — | $24,000 | $30,000 |
| Cost of revenue | — | — | $0 | $0 | $0 | — | $2,000 | $1,000 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | — | $-3M | $-3M | $-3M | — | $-3M | $-3M |
| Net income | $-1M | — | $-3M | $-3M | $-3M | — | $-3M | $-3M |
| EPS (diluted) | $-0.25 | — | $-1.03 | $-0.98 | $-1.14 | — | $-2.28 | $-1.68 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2M | $5M | $4M | $7M | $9M | $11M | $1M | $3M |
| Inventory | — | — | — | — | — | — | $0 | $640,000 |
| Total current assets | $3M | $7M | $6M | $8M | $10M | $12M | $2M | $5M |
| Total assets | $4M | $7M | $7M | $10M | $12M | $15M | $4M | $7M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $6M | $8M | $3M | $3M | $2M | $4M | $3M | $3M |
| Total equity | $-2M | $-1M | $4M | $7M | $10M | $10M | $364,000 | $4M |
Implied volatility — last 90 days
No IV snapshots yet for VIVS.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
VIVS earnings FAQ
When is VIVS's next earnings date?
VivoSim Labs, Inc. is expected to report on November 5, 2026.